CODEINUM PHOSPHORICUM FORTE 10 cpr

Logo Codeinum phosphoricum Compren 50 mg 10 tabletten

CODEINUM PHOSPHORICUM FORTE 10 cpr ACTIVE INGREDIENTS Codeinphosphat – Hemihydrat In compliance with legal requirements, it is not possible for us to provide any information concerning our drugs or infomation related to health issues, for which we encourage you to contact your physician

CODEINUM PHOSPHORICUM NORM 10 cpr

Logo Codeinum phosphoricum Compren 30 mg 10 tabletten

CODEINUM PHOSPHORICUM NORM 10 cpr ACTIVE INGREDIENTS Codeinphosphat – Hemihydrat In compliance with legal requirements, it is not possible for us to provide any information concerning our drugs or infomation related to health issues, for which we encourage you to contact your physician

CODEINUM PHOSPHORICUM NORM 20 cpr

Logo Codeinum phosphoricum Compren 30 mg 20 tabletten

CODEINUM PHOSPHORICUM NORM 20 cpr ACTIVE INGREDIENTS Codeinphosphat – Hemihydrat For more information https://neukoenigsfoerder.de/ In compliance with legal requirements, it is not possible for us to provide any information concerning our drugs or infomation related to health issues, for which we encourage you to contact your physician

CODEINUM PHOSPHORICUM FORTE 20 cpr

Logo Codeinum phosphoricum Compren 50 mg 20 tabletten

CODEINUM PHOSPHORICUM FORTE 20 cpr ACTIVE INGREDIENTS Codeinphosphat – Hemihydrat In compliance with legal requirements, it is not possible for us to provide any information concerning our drugs or infomation related to health issues, for which we encourage you to contact your physician

KALINOR RETARD

Logo Kalinoe® Retard P

KALINOR RETARD ACTIVE INGREDIENTS Kaliumchlorid In compliance with legal requirements, it is not possible for us to provide any information concerning our drugs or infomation related to health issues, for which we encourage you to contact your physician

KALINOR

Logo Kalinor®

KALINOR ACTIVE INGREDIENTS Kaliumcitrat In compliance with legal requirements, it is not possible for us to provide any information concerning our drugs or infomation related to health issues, for which we encourage you to contact your physician

AKINETON Retard 4mg

Logo Akineton 4 mg

AKINETON Retard 4mg ACTIVE INGREDIENTS Biperiden Hydrochloride In compliance with legal requirements, it is not possible for us to provide any information concerning our drugs or infomation related to health issues, for which we encourage you to contact your physician

AKINETON 2mg

Logo Akineton 2 mg

AKINETON 2mg ACTIVE INGREDIENTS Biperiden Hydrochloride For more information https://neukoenigsfoerder.de/ In compliance with legal requirements, it is not possible for us to provide any information concerning our drugs or infomation related to health issues, for which we encourage you to contact your physician

AKINETON Vials

Logo Akineton Vials

AKINETON Vials ACTIVE INGREDIENTS Biperiden Hydrochloride In compliance with legal requirements, it is not possible for us to provide any information concerning our drugs or infomation related to health issues, for which we encourage you to contact your physician

CPhI Worldwide – 24/26 October 2023

Titelblatt Pressemitteilung SIT

SIT Group takes part in the international exhibition of the pharmaceutical world: CPhI Worldwide from 24 to 26 october 2023 in Barcelona, Spain, stand 2N30.